Гефтесса - analogs
Components: Gefitinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors || Antitumor drugs other |
|||||||||
Prices in pharmacies: — Instructions Гефтесса | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . КОМПЛИВИТ Формула роста волос ✘ (incl) Arthris-clinic ✘ (incl) Doverine ✘ (incl) Нарунел ✘ (incl) Acsbirin ✘ (incl) ЮНИВИТ Кидс с Омега 3 и холином ✘ (incl) Зиртал-10 ✘ (incl) Norepinephrine ✘ (incl) Pregnacare ✘ (incl) Coamid ✘ (incl) Prajmalium bitartrate ✘ (incl) Cacao ✘ (incl) Chloropyramine ✘ (incl) Insuran R ✘ (incl) Ambra/Coffea composita ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Iressa neutral | 1114€ |
≈100% | Gefitinib neutral | — |
≈100% | Gefitinib-TL neutral | — |
≈100% | Gefitinib-nativ neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 31% 190.2-195.7€ Зенлистик neutral [Abemaciclib]
- 30% 291.9-1935.3€ Inlyta neutral [Axitinib]
- 29% 363.3-1164.9€ Afinitor neutral [Everolimus and more 1Butylated hydroxytoluene]
- 28% 862.9€ Vargatef neutral [Nintedanib]
- 26% — Carboplatin- BM neutral [Carboplatin]
- 25% 1768-1810.3€ Stivarga neutral [Regorafenib]
- 24% 114.4-127.7€ Glivec neutral [Imatinib]
- 24% 42.3-61€ Philachromin FS neutral [Imatinib]
- 23% — Carbotera neutral [Carboplatin]
- 23% 4-21.5€ Carboplatin neutral [Carboplatin]
- 23% 22€ Carboplatin-LANS neutral [Carboplatin]
- 23% 1€ Paract neutral [Carboplatin]
- 23% — Blastocarb neutral [Carboplatin]
- 23% 86.8€ Hycamtin neutral [Topotecan]
- 23% — Carboplatin-Ebewe neutral [Carboplatin]
- 23% 9.3€ Carboplatin-Teva neutral [Carboplatin]
- 23% 28.5€ Topotecan Actavis neutral [Topotecan]
- 23% 29.1€ Карбоплатин-РОНЦ neutral [Carboplatin]
- 23% 9-23.1€ Kemocarb neutral [Carboplatin]
- 23% — Cycloplatin neutral [Carboplatin]
- 22% 79-86.8€ Natulan neutral [Procarbazine]
- 22% 830-1485.8€ Nexavar neutral [Sorafenib]
- 22% — Imatinib neutral [Imatinib]
- 22% — Сорафениба тозилат neutral [Sorafenib]
- 22% — Албитиниб neutral [Imatinib]
- 22% — Genfatinib neutral [Imatinib]
- 22% 162.9€ Verotekan neutral [Topotecan]
- 22% — Paraplatin neutral [Carboplatin]
- 22% — Иматиниб-Сигардис neutral [Imatinib]
- 22% — Сорафениб-натив neutral [Sorafenib]
- 22% — Сорафениб геми-тозилат моногидрат neutral [Sorafenib]
- 22% 18€ Топотекан-Тева neutral [Topotecan]
- 22% — Сорафениб-АМЕДАРТ neutral [Sorafenib]
- 22% — Флутриксан neutral [Sorafenib]
- 22% — Сорафениб-промомед neutral [Sorafenib]
- 21% — Mitoxantron hydrochloride neutral [Mitoxantrone]
- 21% 1732.5€ Lenvima neutral [Lenvatinib]
- 21% 4850€ Imbruvica neutral [Ibrutinib]
- 21% — Mitolek neutral [Mitoxantrone]
- 21% 23.4€ Mitoxantron-LANS neutral [Mitoxantrone]
- 21% — Mitoxantron neutral [Mitoxantrone]
- 21% 48.7€ Philachromin neutral [Imatinib]
- 21% 43.5-44€ Oncotrone neutral [Mitoxantrone]
- 21% — Mitoxantron AWD 25 neutral [Mitoxantrone]
- 21% — Mitoxantron AWD neutral [Mitoxantrone]
- 21% — Ириноплат neutral [Carboplatin]
- 20% — Erlotinib neutral [Erlotinib]
- 20% — Топотекана гидрохлорид neutral [Topotecan]
- 20% 1645€ Cyramza neutral [Ramucirumab]
- 19% 153.1-1937.3€ Sutent neutral [Sunitinib]
Learn more about the selection of analogues
- The drug has «Гефтесса» 12 full analogs, the cheapest - Iressa (1114€); 51 analog by action, the most similar - Inlyta (291.9-1935.3€).
- Medical online service has selected the best substitutes for Гефтесса based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Гефтесса analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.